The central expert committee formed by the Health Ministry to decide compensation for patients affected by faulty hip implants of Johnson and Johnson held its first meeting on Tuesday.
An expert panel, constituted earlier by the ministry to investigate complaints about faulty articular surface replacement (ASR) hip implant devices, said in its report that the pharma giant "suppressed" facts on the harm of surgeries afterwards which was conducted on patients in India using the "faulty" systems.
The Centre constituted the five-member expert committee to determine the quantum of compensation to be given to patients who have "faulty" hip implants, manufactured by DePuy International, a subsidiary of Johnson and Johnson.
According to sources in the ministry, the terms of reference (ToR) of the committee was discussed in the meeting.
The committee is now scheduled to meet next week, sources said.
The new five-member central committee is being chaired by R K Arya, director, Sports Injury Centre, Safdurjung Hospital.
Others in the committee include C S Yadav, department of Orthopaedics, AIIMS in New Delhi, Vineet Sharma, Head of Department of Orthopaedics, King George's Medical University in Lucknow, Bikas Medhi, professor pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, and Bhushan Tilak Kaul, professor of law in the Delhi University.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
